Vimarsana
Biggest News Aggregation in the World

Darrell Rigel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Darrell Rigel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Darrell Rigel Today - Breaking & Trending Today

Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma - Vimarsana News

Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma

Studies have shown that using Castle’s DecisionDx®-Melanoma test to help guide the care of patients with melanoma, the deadliest form of skin cancer, improves health outcomes1-5 Castle’s...

Exosome Therapy Is Ushering in the Next Generation of Skin and Hair Rejuvenation - Vimarsana News

Exosome Therapy Is Ushering in the Next Generation of Skin and Hair Rejuvenation

Dr. Julie Russak, Dr. Sanjay Batra, and Dr. Elizabeth Houshmand explain what exosome therapy is and how it can work for hair and skin.

Here's the SPF Number You Should Buy This Summer, According to Doctors | KOST 103.5 - Vimarsana News

Here's the SPF Number You Should Buy This Summer, According to Doctors | KOST 103.5

Roughly one in five Americans will eventually develop some form of skin cancer over their lifetime

Source: iheart.com
What SPF should your sunscreen have? Find out how it may help premature aging and skin cancer - Vimarsana News

What SPF should your sunscreen have? Find out how it may help premature aging and skin cancer

While fun in the sun may be top of mind this summer, make sure to put on your sunscreen and safe clothing to avoid skin cancer and other risks from sunburn.

SciBase: New study shows Nevisense significantly improves US clinician's decision-making beyond dermoscopy - Vimarsana News

SciBase: New study shows Nevisense significantly improves US clinician's decision-making beyond dermoscopy

STOCKHOLM, Oct. 26, 2022 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a